Lucid Diagnostics Inc. (NASDAQ: LUCD)
$0.89
+0.0123 ( +1.41% ) 24.4K
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Market Data
Open
$0.89
Previous close
$0.87
Volume
24.4K
Market cap
$45.86M
Day range
$0.85 - $0.89
52 week range
$0.63 - $1.72
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Feb 23, 2024 |
4 | Insider transactions | 2 | Feb 23, 2024 |
4 | Insider transactions | 2 | Feb 23, 2024 |
4 | Insider transactions | 1 | Feb 23, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
8-k | 8K-related | 14 | Jan 30, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |
8-k | 8K-related | 12 | Nov 28, 2023 |
8-k | 8K-related | 12 | Nov 24, 2023 |
8-k | 8K-related | 13 | Nov 14, 2023 |